Tilray Brands Inc vs Vanguard Ultra Short Bond ETF — how do they compare? Tilray Brands Inc trades at $3.64 (market cap $549.01M), while Vanguard Ultra Short Bond ETF trades at $49.47 (market cap $10.20B). The key difference: Vanguard Ultra Short Bond ETF is far larger — about 18.6× Tilray Brands Inc's market cap, and Tilray Brands Inc is more actively traded (3,292,073 versus 3,032,339). Which is the better fit depends on your goals — on Pluang, investors hold Tilray Brands Inc for 31 Days and Vanguard Ultra Short Bond ETF for 61 Days on average.
| TLRY | VUSB | |
|---|---|---|
Market Cap | $549.01M | $10.20B |
Volume | 3,292,073 | 3,032,339 |
Sector | Health | Leveraged / Inverse |
52-Week High | $21.00 | $50.03 |
52-Week Low | $3.57 | $49.41 |
Typical Hold Time | 31 Days | 61 Days |
Enterprise Value | $716.15M | — |
Signals from Pluang's Aura AI — not financial advice
Tilray Brands (TLRY) trades at $3.715, down 1.72% on the day, as the stock continues to face significant pressure with bearish technical signals and fundamental challenges. The company reported a substantial net loss of $2.19 billion in 2025 despite $821 million in revenue, with negative cash flow from operations of $94.6 million. Recent earnings have consistently missed expectations, and technical indicators show a bearish trend with the stock trading near key support levels.
While TLRY shows attractive valuation metrics with P/S of 0.45 and P/B of 0.34, the company faces substantial execution risks amid persistent losses and negative cash flow. Analyst sentiment remains cautious with only 25% buy ratings, though the consensus price target of $65.01 suggests significant upside potential if the company can achieve profitability and growth targets.
VUSB trades at $49.48, up 0.08% with minimal daily movement. Technical indicators show a bearish trend with moving averages signaling sell pressure, though oscillators remain neutral. The stock faces resistance at $50 and support at $49. Recent news highlights potential benefits from short-term bond strategies amid Federal Reserve rate uncertainty.
The outlook remains cautious due to bearish technical signals and interest rate sensitivity. Opportunities include dividend stability with recent payouts, but risks involve Fed policy shifts and market volatility. Investors should weigh short-term bond appeal against broader economic headwinds.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →VUSB is an actively managed ETF from Vanguard that invests in a diversified portfolio of high-quality, investment-grade fixed income securities with maturities typically under two years. It is designed to offer higher yield potential than traditional money market funds while maintaining limited price volatility, making it a strategic tool for managing short-term reserves with a 6-to-18-month horizon.
Read more on VUSB →